Cargando…

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

BACKGROUND: Novel drug regimens are needed for tuberculosis (TB) treatment. New regimens aim to improve on characteristics such as duration, efficacy, and safety profile, but no single regimen is likely to be ideal in all respects. By linking these regimen characteristics to a novel regimen’s abilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kendall, Emily A., Shrestha, Sourya, Cohen, Ted, Nuermberger, Eric, Dooley, Kelly E., Gonzalez-Angulo, Lice, Churchyard, Gavin J., Nahid, Payam, Rich, Michael L., Bansbach, Cathy, Forissier, Thomas, Lienhardt, Christian, Dowdy, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207633/ https://www.ncbi.nlm.nih.gov/pubmed/28045934 http://dx.doi.org/10.1371/journal.pmed.1002202

Ejemplares similares

Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis
por: Shrestha, Sourya, et al.
Publicado: (2014)

Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
por: Lienhardt, Christian, et al.
Publicado: (2019)

Reply to Pierce: Subclinical Tuberculosis: Some Flies in the Ointment
por: Kendall, Emily A., et al.
Publicado: (2021)

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
por: Falzon, Dennis, et al.
Publicado: (2017)

Advances in clinical trial design for development of new TB treatments: A call for innovation
por: Lienhardt, Christian, et al.
Publicado: (2019)

Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis
por: Vesga, Juan F., et al.
Publicado: (2022)

A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis
por: Fofana, Mariam O., et al.
Publicado: (2017)

Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations
por: Kendall, Emily A., et al.
Publicado: (2019)

Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies
por: Zwerling, Alice, et al.
Publicado: (2015)

Priorities for tuberculosis research: a systematic review
por: Rylance, Jamie, et al.
Publicado: (2010)

Mathematical Modeling of “Chronic” Infectious Diseases: Unpacking the Black Box
por: Fojo, Anthony T, et al.
Publicado: (2017)

Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
por: Velásquez, Gustavo E., et al.
Publicado: (2023)

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review
por: Chimoyi, Lucy Andere, et al.
Publicado: (2020)

Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
por: Kendall, Emily A, et al.
Publicado: (2017)

Treatment-shortening regimens for tuberculosis: updates and future priorities
por: Saluzzo, Francesca, et al.
Publicado: (2023)

Sevoflurane in combination with esketamine is an effective sedation regimen in COVID-19 patients enabling assisted spontaneous breathing even during prone positioning
por: Bansbach, Joachim, et al.
Publicado: (2022)

Research Questions and Priorities for Tuberculosis: A Survey of Published Systematic Reviews and Meta-Analyses
por: Nicolau, Ioana, et al.
Publicado: (2012)

The Importance of Heterogeneity to the Epidemiology of Tuberculosis
por: Trauer, James M, et al.
Publicado: (2019)

Cost‐effectiveness of a 12 country‐intervention to scale up short course TB preventive therapy among people living with HIV
por: Shin, Hyejeong, et al.
Publicado: (2020)

The epidemiology of blindness in children: changing priorities
por: Gilbert, Clare, et al.
Publicado: (2017)

Achieving a “step change” in the tuberculosis epidemic through comprehensive community-wide intervention: a model-based analysis
por: Shrestha, Sourya, et al.
Publicado: (2021)

Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach
por: Ryckman, Theresa, et al.
Publicado: (2023)

Cost‐effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda
por: Ferguson, Olivia, et al.
Publicado: (2020)

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
por: Phillips, Patrick P. J., et al.
Publicado: (2019)

Advances in clinical trial design: Weaving tomorrow’s TB treatments
por: Lienhardt, Christian, et al.
Publicado: (2020)

Priorities for global political momentum to end TB: a critical point in time
por: Kasaeva, Tereza, et al.
Publicado: (2018)

The role of influenza in the epidemiology of pneumonia
por: Shrestha, Sourya, et al.
Publicado: (2015)

TB and HIV Therapeutics: Pharmacology Research Priorities
por: Dooley, Kelly E., et al.
Publicado: (2012)

Priority Setting: Right Answer to a Far Too Narrow Question?: Comment on "Global Developments in Priority Setting in Health"
por: Schrecker, Ted
Publicado: (2017)

Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
por: Dooley, Kelly E., et al.
Publicado: (2020)

Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries
por: Jo, Youngji, et al.
Publicado: (2021)

Indigenous Epidemiology: Identifying Health Disparities and Health Priorities
por: Dominguez, Adrian, et al.
Publicado: (2019)

Top 10 Research Priorities in Spatial Lifecourse Epidemiology
por: Jia, Peng, et al.
Publicado: (2019)

What We Know About Tuberculosis Transmission: An Overview
por: Churchyard, Gavin, et al.
Publicado: (2017)

A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way
por: Deshpande, Devyani, et al.
Publicado: (2016)

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)

Comparison of the ‘Denver regimen’ against acute tuberculosis in the mouse and guinea pig
por: Ahmad, Zahoor, et al.
Publicado: (2010)

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground
por: Srivastava, Shashikant, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m5o3ii4g96obq8d60cenmi377s